Literature DB >> 34213400

Human Vaccines & Immunotherapeutics: News.

.   

Abstract

Entities:  

Year:  2021        PMID： 34213400      PMCID： PMC8827631          DOI： 10.1080/21645515.2021.1940537

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   4.526


× No keyword cloud information.
  3 in total

1.  Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data.

Authors:  Robert H Shaw; Arabella Stuart; Melanie Greenland; Xinxue Liu; Jonathan S Nguyen Van-Tam; Matthew D Snape
Journal:  Lancet       Date:  2021-05-12       Impact factor: 79.321

2.  A phase I study assessing the safety, tolerability, immunogenicity, and low-density lipoprotein cholesterol-lowering activity of immunotherapeutics targeting PCSK9.

Authors:  Markus Zeitlinger; Martin Bauer; Roman Reindl-Schwaighofer; Robert M Stoekenbroek; Gilles Lambert; Evelyn Berger-Sieczkowski; Heimo Lagler; Zoe Oesterreicher; Beatrix Wulkersdorfer; Petra Lührs; Gergana Galabova; Carsten Schwenke; Robert M Mader; Rossella Medori; Christine Landlinger; Alexandra Kutzelnigg; Günther Staffler
Journal:  Eur J Clin Pharmacol       Date:  2021-05-10       Impact factor: 2.953

3.  Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.

Authors:  Jamie Lopez Bernal; Nick Andrews; Charlotte Gower; Eileen Gallagher; Ruth Simmons; Simon Thelwall; Julia Stowe; Elise Tessier; Natalie Groves; Gavin Dabrera; Richard Myers; Colin N J Campbell; Gayatri Amirthalingam; Matt Edmunds; Maria Zambon; Kevin E Brown; Susan Hopkins; Meera Chand; Mary Ramsay
Journal:  N Engl J Med       Date:  2021-07-21       Impact factor: 91.245
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.